Home
R StocksTrader Stocks Live Prices
Protalix BioTherapeutics Inc.

Protalix BioTherapeutics Inc.

Available to platforms

Protalix BioTherapeutics Inc. (Ticker: PLX) is a biopharmaceutical company specializing in the development and production of recombinant therapeutic proteins using its proprietary ProCellEx® plant cell-based protein expression system. The company's lead product, Elelyso® (taliglucerase alfa), is approved for the treatment of Gaucher disease. Protalix is also advancing a pipeline of treatments for other rare diseases, including Fabry disease and cystic fibrosis. Its innovative approach aims to provide cost-effective and scalable therapies for unmet medical needs.

Protalix BioTherapeutics Inc. - PLX stocks live chart

Analyze price movements of Protalix BioTherapeutics Inc. online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous PLX quotes – including the latest bid at 2.58 USD and ask at 2.65 USD – and get all the necessary information for adding Protalix BioTherapeutics Inc. to your investment portfolio.

With R StocksTrader, you can invest in Protalix BioTherapeutics Inc. and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Protalix BioTherapeutics Inc., and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of PLX does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Protalix BioTherapeutics Inc. (PLX).

You can trade Protalix BioTherapeutics Inc. (PLX) on the R StocksTrader platform.

You can trade online Protalix BioTherapeutics Inc. (PLX) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts